Chemoinformaics analysis of Benzene, (1,2-dimethoxyethyl)-
| Molecular Weight | 166.22 | nRot | 4 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 6 |
| Exact Molecular Weight | 166.099 | nRing | 1 |
| Solubility: LogS | -1.348 | nHRing | 0 |
| Solubility: LogP | 1.492 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 27.6391 |
| nHD | 0 | BPOL | 17.5169 |
| QED | 0.681 |
| Synth | 2.346 |
| Natural Product Likeliness | 0.063 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.145 |
| HIA | 0.003 |
| CACO-2 | -4.178 |
| MDCK | 0.0000416 |
| BBB | 0.773 |
| PPB | 0.502837 |
| VDSS | 1.928 |
| FU | 0.334922 |
| CYP1A2-inh | 0.096 |
| CYP1A2-sub | 0.799 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.83 |
| CYP2c9-inh | 0.021 |
| CYP2c9-sub | 0.057 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.376 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.537 |
| CL | 7.109 |
| T12 | 0.264 |
| hERG | 0.068 |
| Ames | 0.823 |
| ROA | 0.089 |
| SkinSen | 0.801 |
| Carcinogencity | 0.672 |
| EI | 0.981 |
| Respiratory | 0.027 |
| NR-Aromatase | 0.024 |
| Antiviral | No |
| Prediction | 0.893554 |